U.S. IVD market 2030

PORTLAND, OREGON, UNITED STATES, July 25, 2023/EINPresswire.com/ -- Market Growth: The U.S. IVD market has experienced steady growth over the years. Factors such as an aging population, the prevalence of chronic diseases, and advances in technology have contributed to the expansion of the market.

Technological Advancements: The IVD industry has witnessed significant technological advancements, leading to the development of innovative diagnostic tests. This includes molecular diagnostics, point-of-care testing, and automation of laboratory processes, which have improved accuracy and efficiency.

COVID-19 Impact: The outbreak of the COVID-19 pandemic in early 2020 had a profound effect on the IVD market. There was a surge in demand for COVID-19 diagnostic tests, including PCR-based tests, antigen tests, and antibody tests, leading to a temporary shift in focus and allocation of resources within the industry.

Regulatory Landscape: The IVD market in the U.S. is subject to strict regulations by the Food and Drug Administration (FDA). Manufacturers need to adhere to rigorous standards and undergo thorough evaluation and approval processes before bringing new IVD products to market.

Consolidation: The IVD industry has experienced consolidation, with larger companies acquiring smaller ones to expand their product portfolios and market presence. This consolidation trend has led to increased competitiveness among key players.

Growing Importance of Personalized Medicine: The field of personalized medicine, which tailors medical treatment to the individual characteristics of each patient, has been gaining prominence. IVD plays a crucial role in enabling personalized medicine by providing precise diagnostic information.

Point-of-Care Testing (POCT) Expansion: Point-of-care testing, which allows for rapid testing and results at or near the patient's location, has seen significant growth. This expansion is driven by the need for quicker diagnosis and treatment decisions, especially in remote or resource-limited settings.

Request Sample Copy of the Report: https://www.alliedmarketresearch.com/request-sample/3817

Market Drivers:

Aging Population: The aging population in the United States has been a significant driver for the IVD market. As people age, the incidence of chronic diseases and conditions increases, leading to a higher demand for diagnostic tests to monitor and manage these health issues.

Prevalence of Chronic Diseases: Chronic diseases such as diabetes, cardiovascular diseases, cancer, and infectious diseases remain major health concerns in the U.S. IVD plays a critical role in the early detection, diagnosis, and monitoring of these conditions, driving demand for relevant diagnostic tests.

Technological Advancements: Advancements in diagnostic technologies and laboratory automation have improved the accuracy, speed, and efficiency of IVD tests. These innovations have expanded the capabilities of diagnostic laboratories and enabled the development of more sophisticated tests.

Request for Customization – https://www.alliedmarketresearch.com/request-for-customization/3817

U.S. IVD Market Segmentation:

Product Type:

Immunochemistry: Tests that detect and measure the presence of antibodies or antigens in the blood to diagnose conditions like infectious diseases, allergies, and autoimmune disorders.
Clinical Chemistry: Tests that analyze chemical components in blood and other body fluids to assess organ function and diagnose conditions such as liver and kidney disorders.
Molecular Diagnostics: Tests that detect genetic material (DNA or RNA) to diagnose genetic disorders, infectious diseases, and cancers.
Hematology: Tests that study blood cells and components to diagnose blood-related disorders.
Coagulation and Hemostasis: Tests that assess blood clotting abilities to diagnose bleeding disorders and monitor anticoagulant therapies.

Application:

Infectious Diseases: Tests used to diagnose bacterial, viral, and fungal infections, including specialized tests for outbreaks like COVID-19.
Oncology: Tests used for cancer screening, diagnosis, prognosis, and treatment monitoring.
Diabetes: Tests to diagnose and monitor diabetes and related complications.
Cardiology: Tests to assess cardiac health, including cardiac markers and lipid profiles.
Autoimmune Diseases: Tests to diagnose conditions where the immune system attacks the body's own tissues.
Others: Additional tests for specific conditions and health assessments.

End-user:

Hospitals: Large hospitals with extensive testing capabilities and laboratories.
Diagnostic Laboratories: Independent clinical laboratories that conduct diagnostic testing.
Physician Offices: Point-of-care testing in medical offices for immediate results.
Academic and Research Institutes: Research-focused institutions that use IVD for scientific studies.
Others: Includes blood banks, home care settings, and public health agencies.

Technology:

Enzyme-Linked Immunosorbent Assay (ELISA)
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Mass Spectrometry
Flow Cytometry
Immunoassays
Others: Various other technologies and methodologies.

Region: The U.S. IVD market can be further segmented by region, considering factors such as regional prevalence of diseases, healthcare infrastructure, and population demographics.

Market Players: Segmentation based on the companies and manufacturers that dominate the market, ranging from large multinational corporations to smaller niche players.

Competitive Landscape:

Roche Diagnostics: A division of F. Hoffmann-La Roche Ltd., Roche Diagnostics is a global leader in IVD with a wide range of products, including clinical chemistry, immunochemistry, molecular diagnostics, and tissue diagnostics.

Abbott Laboratories: Abbott is a diversified healthcare company with a strong presence in IVD. They offer a broad portfolio of diagnostic products, including tests for infectious diseases, oncology, diabetes, and cardiovascular disorders.

Siemens Healthineers: Siemens Healthineers is a leading player in the IVD market, providing a comprehensive range of diagnostic solutions, including clinical chemistry, immunoassays, point-of-care testing, and molecular diagnostics.

BD (Becton, Dickinson, and Company): BD is a prominent player in the IVD industry, offering a wide array of products, including blood collection systems, microbiology solutions, molecular diagnostics, and point-of-care testing.

bioMérieux: bioMérieux is a global company specializing in infectious disease diagnostics, clinical microbiology, and molecular diagnostics. They are known for their high-quality diagnostic solutions.

Buy this Premium Research Report: https://www.alliedmarketresearch.com/purchase-enquiry/3817

VALUE PROPOSITIONS RELATED TO THE REPORT:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

Comprehensive quantitative and qualitative insights at segment and sub-segment level

Covid 19 impact trends and perspective

Granular insights at global/regional/country level

Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Browse more latest healthcare reports:

Advanced Wound Care Market

Defibrillator Market

About Us:

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions.

Allied Market Research
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.